title: Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium.
abstract: The effects of 17 beta-estradiol and tamoxifen (TAM) on the proliferation of responsive MCF-7 and unresponsive HBC-4 human breast cancer cells were studied in a defined culture medium containing insulin (2 micrograms/ml), transferrin (2 micrograms/ml), ethanolamine (2 microM), and selenite (25 nM). MCF-7 cells grew at a population-doubling rate of 2.0 days in serum-free medium and at a rate of 1.7 days in the medium containing 1 mg/ml of the 55-70% ammonium sulfate fraction of bovine serum or 1% dextrancoated charcoal-treated fetal bovine serum. Increasing concentrations of the ammonium sulfate fraction and/or dextran-coated charcoal-treated fetal bovine serum increasingly inhibited the growth of MCF-7 cells but did not inhibit HBC-4 cell growth, indicating that such serum preparations contain some growth inhibitor specific for estradiol-responsive MCF-7 cells. A sufficiently high concentration of exogenous estradiol (100 pM) had the dual action of neutralizing the growth inhibition by the 55-70% ammonium sulfate fraction of bovine serum and dextran-treated charcoal-treated fetal bovine: serum and enhancing directly the MCF-7 cell growth maximally 2-fold. Bovine serum albumin fraction V containing globulin remnants also inhibited growth, but globulin-free bovine serum albumin did not. Eliminating growth inhibition by the use of globulin-free bovine serum albumin enabled us to develop an ideal medium for assaying the direct effects of estradiol and TAM on MCF-7 cells. With this medium, we clearly identified (a) a direct mitogenic effect of exogenous estradiol on MCF-7 cells which was initiated at 3 pM and maximized at 0.2 to 10 nM, (b) an acute lethal effect of 1 microM TAM and its prevention by 100 pM estradiol, and (c) a nearly 50-fold increase in the concentration of exogenous estradiol (10 nM) required for maximum growth enhancement in the presence of 1 microM TAM than without TAM (0.2-0.3 nM).
authors.affiliation: Department of Surgery, Hyogo Medical Center for Adults, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Furuya
authors.forename: N
authors.initials: N
authors.lastname: Kohno
authors.forename: Y
authors.initials: Y
authors.lastname: Fujiwara
authors.forename: Y
authors.initials: Y
authors.lastname: Saitoh
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology*; D002455:Cell Division; D003470:Culture Media; D004958:Estradiol / Q000494:pharmacology*; D006131:Growth Inhibitors; D006801:Humans; D066298:In Vitro Techniques; D013629:Tamoxifen / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000166:cytology
chemical_list: D003470:Culture Media; D006131:Growth Inhibitors; D013629:Tamoxifen; D004958:Estradiol